Loading…
OSR Health, Inc. is projected to rise to $0.4086 by 2027, a +26% move from its current price of $0.3231. OSRH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.3098 | $0.3233 | $0.3373 | +0.05% |
| Jul 13 | $0.3046 | $0.3234 | $0.3435 | +0.11% |
| Jul 14 | $0.3007 | $0.3236 | $0.3483 | +0.16% |
| Jul 15 | $0.2974 | $0.3238 | $0.3525 | +0.21% |
| Jul 16 | $0.2946 | $0.324 | $0.3562 | +0.26% |
| Jul 17 | $0.2921 | $0.3241 | $0.3596 | +0.32% |
| Jul 18 | $0.2898 | $0.3243 | $0.3628 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2898 | $0.3243 | $0.3628 | +0.37% |
| Week 2 | $0.2777 | $0.3255 | $0.3815 | +0.74% |
| Week 3 | $0.2689 | $0.3267 | $0.3969 | +1.11% |
| Week 4 | $0.2619 | $0.3279 | $0.4105 | +1.49% |
| Week 5 | $0.256 | $0.3291 | $0.4231 | +1.86% |
| Week 6 | $0.2509 | $0.3303 | $0.435 | +2.24% |
| Week 7 | $0.2463 | $0.3316 | $0.4463 | +2.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OSR Health, Inc. is a healthcare holding company that develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1.
It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical devices and systems. The company was formerly known as OSR Holdings, Inc.
and changed its name to OSR Health, Inc. in June 2026. OSR Health, Inc. was incorporated in 2020 and is based in Bellevue, Washington.
OSR Health, Inc. (OSRH) is a healthcare holding company with a diversified portfolio spanning immunotherapy products, preclinical assets, and medical devices. The stock currently trades at $0.3077 per share and has a market cap of $10.8M, ranking 5096. The price outlook reflects a multi-year forecast with periods of neutral and bullish sentiment.
A major floor 34.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.7% below — buyers have tended to step in here.
The nearest ceiling, 42.4% above — a clean break opens room to run.
A major ceiling 130.3% above — clearing it would confirm fresh momentum.
Key OSRH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OSRH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3208 | Buy | $0.3229 | Buy |
| MA 10 | $0.3206 | Buy | $0.3274 | Sell |
| MA 20 | $0.3465 | Sell | $0.3504 | Sell |
| MA 50 | $0.4475 | Sell | $0.4156 | Sell |
| MA 100 | $0.4745 | Sell | $0.4854 | Sell |
| MA 200 | $0.5472 | Sell | $0.8853 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.03 | Neutral |
| Stoch RSI (14) | 97.68 | Sell |
| CCI (20) | -41.92 | Neutral |
| Williams %R (14) | -67.21 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -9.14 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 32.79 | Neutral |
| TRIX (15) | -1.44 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 47.80 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 0.32 | Buy |
| ADX (14) | 26.99 | Sell |
| ATR (14) | 0.01 | Info |
The near-term technical picture shows a NEUTRAL sentiment with RSI14 at 30. The stock trades below notable moving averages, with SMA50 at $0.4637 and SMA200 at $0.5514, indicating resistance above current levels. Support is identified at $0.308 and resistance at $0.495.
The 30-day range spans from a low of $0.2327 to a high of $0.4069, highlighting meaningful near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.308 | $0.3231 | $0.4514 | 0% | Neutral | |
| $0.3085 | $0.4086 | $0.5813 | +26% | Bullish | |
| $0.2643 | $0.3666 | $0.55 | +13% | Neutral | |
| $0.2714 | $0.3913 | $0.6118 | +21% | Bullish | |
| $0.2555 | $0.3815 | $0.6171 | +18% | Neutral | |
| $0.2102 | $0.3241 | $0.54 | 0% | Neutral | |
| $0.2221 | $0.3531 | $0.604 | +9% | Neutral | |
| $0.2563 | $0.4193 | $0.7344 | +30% | Bullish | |
| $0.2942 | $0.495 | $0.886 | +53% | Bullish | |
| $0.2969 | $0.5132 | $0.937 | +59% | Bullish | |
| $0.289 | $0.5669 | $1.12 | +75% | Bullish | |
| $0.4693 | $1.04 | $2.33 | +223% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.308 | $0.3231 | $0.3825 | +0.00% |
| August 2026 | $0.2634 | $0.3157 | $0.3919 | -2.30% |
| September 2026 | $0.2798 | $0.339 | $0.4279 | +7.40% |
| October 2026 | $0.2854 | $0.3491 | $0.4469 | +2.98% |
| November 2026 | $0.275 | $0.3392 | $0.4393 | -2.85% |
| December 2026 | $0.2774 | $0.3448 | $0.4514 | +1.65% |
Click any year to see its month-by-month OSRH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, OSRH could reach as high as $0.4514, with a base case around $0.3231 and support toward $0.308 — roughly 0% from $0.3231. A consolidation phase looks the most probable path here.
Expect OSRH to range from $0.3085 to $0.5813 through 2027. The $0.4086 average target implies a +26% move from current prices. That is up +26% on the projected 2026 average. Momentum favours further upside here.
The OSRH price prediction for 2028 points to an average of $0.3666 (low $0.2643, high $0.55) — a potential gain of +13% on today's $0.3231. A consolidation phase looks the most probable path here.
In 2029, OSRH is projected to trade between $0.2714 and $0.6118, averaging $0.3913 — a potential gain of +21% from today's $0.3231. That is up +7% on the projected 2028 average. Momentum favours further upside here.
OSR Health, Inc.'s 2030 outlook centres on $0.3815, within a $0.2555 to $0.6171 range. That is -3% versus the projected 2029 average. That marks a +18% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, OSRH could reach as high as $0.54, with a base case around $0.3241 and support toward $0.2102 — roughly 0% from $0.3231. Price action looks broadly range-bound.
Expect OSRH to range from $0.2221 to $0.604 through 2032. The $0.3531 average target implies a +9% move from current prices. That is up +9% on the projected 2031 average. A consolidation phase looks the most probable path here.
The OSRH price prediction for 2033 points to an average of $0.4193 (low $0.2563, high $0.7344) — a potential gain of +30% on today's $0.3231. Momentum favours further upside here.
In 2034, OSRH is projected to trade between $0.2942 and $0.886, averaging $0.495 — a potential gain of +53% from today's $0.3231. That is up +18% on the projected 2033 average. Buyers look set to stay in control over this stretch.
OSR Health, Inc.'s 2035 outlook centres on $0.5132, within a $0.2969 to $0.937 range. That is up +4% on the projected 2034 average. That marks a +59% change versus current levels. Momentum favours further upside here.
By 2040, OSRH could reach as high as $1.12, with a base case around $0.5669 and support toward $0.289 — roughly +75% from $0.3231. Buyers look set to stay in control over this stretch.
Expect OSRH to range from $0.4693 to $2.33 through 2050. The $1.04 average target implies a +223% move from current prices. That is up +84% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OSRH today (≈ 3,095.017023 OSRH) could be worth
$3,227.69
+$2,227.69 (+223%) by 2050 · US Dollar
Based on the average projected OSRH price of $1.04 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OSRHwould be worth at today's price.
$1,000 invested in OSRH on Jul 10, 2025 (≈ 826.446255 OSRH) would be worth
$267.02
-$732.98 (-73.3%) today · 0.27× · US Dollar
Based on a OSRH entry price of $1.21 vs. today's $0.3231.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.321 | $1,006.54 | +0.7% |
| 1 month ago | $0.418 | $772.97 | -22.7% |
| 3 months ago | $0.535 | $603.93 | -39.6% |
| 6 months ago | $0.717 | $450.63 | -54.9% |
| 1 year ago | $1.21 | $267.02 | -73.3% |
| All time (3.3y) ago | $10.1 | $31.99 | -96.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OSRH forecast.
Our base-case forecast reaches $0.65 around 2050.
Implied market cap at $0.65: $22.82M
The year-by-year forecast reveals a bullish tilt beyond 2026, with the 2027 average at $0.3913 and ROI of 27.2%. The 2029–2030 window remains bullish, with 2030 averaging $0.3693 and ROI of 20%. The longer horizon shows sizable upside, including 2034 average $0.4732 with a max $0.8466 and ROI of 53.8%, 2035 average $0.497 with a max $0.9071 and ROI of 61.5%, 2040 average $0.5381 with a max $1.07 and ROI of 74.9%, and 2050 average $1.01 with a max $2.26 and ROI of 228.8.
The forecast includes a mix of neutral and bullish years, with ongoing volatility, exemplified by an annualized volatility of 80. These figures are estimates of future prices and outcomes, not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average of $0.3693 with a range from $0.2474 to $0.5972 and an ROI of 20%.
The forecast features a mix of Neutral and Bullish years, including a Bullish 2027 with average $0.3913 and ROI 27.2%, and bullish years in 2034 and 2050 (average $0.4732 and $1.01, with corresponding highs). These are estimates, not guarantees.
Yes. The 2040 forecast max is $1.07 and the 2050 forecast max is $2.26.
Current price is $0.3077 and market cap is $10.8M.
The 2027 ROI is 27.2% with an average price of $0.3913.
OSR Health, Inc. Community Discussion
0Share your OSR Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.